Tesamorelin & Ipamorelin 10/5 15mg
Tesamorelin & Ipamorelin 10/5 mg combines two well-studied investigational peptides Ipamorelin, a selective ghrelin-receptor agonist (GHS), and Tesamorelin, a stabillized GHRH analogue. Together, they are frequently examined for their complementary roles in growth-hormone-related pathways, metabolic signaling, and cellular-repair research models.
$169
- All products provided on this website are intended strictly for laboratory research and development purposes. These products are not intended for human use or consumption in any form. The statements presented on this site have not been reviewed or approved by the United States Food and Drug Administration (FDA). Neither the information nor the products offered are meant to diagnose, treat, cure, or prevent any medical condition.
Tesamorelin & Ipamorelin 10/5 mg combines two well-studied investigational peptides Ipamorelin, a selective ghrelin-receptor agonist (GHS), and Tesamorelin, a stabillized GHRH analogue. Together, they are frequently examined for their complementary roles in growth-hormone-related pathways, metabolic signaling, and cellular-repair research models.
- All products provided on this website are intended strictly for laboratory research and development purposes. These products are not intended for human use or consumption in any form. The statements presented on this site have not been reviewed or approved by the United States Food and Drug Administration (FDA). Neither the information nor the products offered are meant to diagnose, treat, cure, or prevent any medical condition.
Tesamorelin & Ipamorelin 10/5 15MG — Research Peptide Blend
Overview:
This blend combines two well-studied investigational peptides—Ipamorelin, a selective ghrelin-receptor agonist (GHS), and Tesamorelin, a stabilized GHRH analogue. Together, they are frequently examined for their complementary roles in growth-hormone–related pathways, metabolic signaling, and cellular-repair research models.
Research Focus (non-clinical):
• Comparative and combined GH pulse modulation
• Studies involving lipid-metabolism markers and IGF-axis signaling
• Investigation of tissue recovery, ECM activity, and cellular-repair cascades
• Evaluating endocrine selectivity with minimal off-target hormonal activity
Key Notes for Investigators:
Ipamorelin is commonly used to study selective GH release without significant prolactin or cortisol spillover, while Tesamorelin supports sustained GHRH-based pathway activation. Together, they offer a dual-pathway approach for exploring GH physiology, metabolic research, and repair-related mechanisms.
Regulatory & Use:
For laboratory research only. Not for human use or veterinary use.
